Protocadherin-12 (PCDH12 or VE-cadherin-2 or VECAD2) Antibody - FFPE Validated

Scientific Overview

This antibody helps you characterize Protocadherin-12 (PCDH12) while keeping condition-to-condition contrasts straightforward. Protocadherin-12 is a membrane-associated component that helps organize cell-cell contacts and polarity. Use matched handling so differences reflect biology rather than processing.

In some datasets and protocols, it is referenced by the gene symbol PCDH12.

Research Relevance

Researchers often monitor junctional targets when studying epithelial integrity, remodeling, and motility. Define inclusion criteria and controls early so replicate sets remain interpretable as the dataset grows.

When cell-state transitions occur, this target may change alongside partners in the same compartment or pathway neighborhood. Planar polarity studies may connect this target to directional signaling and cytoskeletal alignment.

When building a narrative around the target, it helps to track:

• comparative profiling across cell states or perturbations
• co-localization patterns with cytoskeletal elements
• subcellular redistribution at contact sites versus cytoplasm
• changes in complex assembly with scaffold or adaptor proteins

Application-Specific Context

In sectioned tissue workflows, interpretation often depends on morphology; this format supports that style of readout. Think about how preparation affects epitope accessibility, and interpret patterns alongside morphology and compartment markers as needed. A short pilot series can help set exposure ranges and reduce reruns.

To support downstream analysis, record key context variables (culture timing, stimulation window, and extraction approach) so Protocadherin-12 patterns can be compared across experiments without guesswork.

For multi-run studies, the fixed-section option helps keep Protocadherin-12 (PCDH12) trends comparable from experiment to experiment.